Baligasa, Normia O.

HRN: 21-41-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2022
CEFUROXIME 1.5GM (VIAL)
05/29/2022
06/05/2022
IV
1.5gm
Q8
Empiric For UTI

 Indication:      Type of Infection:      Compliance to guidelines: Non-compliant To Guidelines